HOLOGIC INC (HOLX) Stock Fundamental Analysis
NASDAQ:HOLX - US4364401012 - Common Stock
66.73 USD
+0.1 (+0.15%)
66.73 USD
0 (0%)
Overall HOLX gets a fundamental rating of 6 out of 10. We evaluated HOLX against 185 industry peers in the Health Care Equipment & Supplies industry. HOLX gets an excellent profitability rating and is at the same time showing great financial health properties. HOLX has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
HOLX had positive earnings in the past year.
In the past year HOLX had a positive cash flow from operations.
HOLX had positive earnings in each of the past 5 years.
HOLX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of HOLX (6.33%) is better than 85.41% of its industry peers.
HOLX has a Return On Equity of 11.50%. This is amongst the best in the industry. HOLX outperforms 88.11% of its industry peers.
The Return On Invested Capital of HOLX (10.03%) is better than 90.81% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for HOLX is above the industry average of 8.44%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.33% | ||
| ROE | 11.5% | ||
| ROIC | 10.03% |
ROA(3y)9.32%
ROA(5y)12.89%
ROE(3y)17.06%
ROE(5y)27.35%
ROIC(3y)11.66%
ROIC(5y)15.25%
1.3 Margins
HOLX's Profit Margin of 13.79% is amongst the best of the industry. HOLX outperforms 90.81% of its industry peers.
In the last couple of years the Profit Margin of HOLX has declined.
HOLX's Operating Margin of 24.55% is amongst the best of the industry. HOLX outperforms 94.05% of its industry peers.
HOLX's Operating Margin has improved in the last couple of years.
HOLX has a Gross Margin of 56.34%. This is comparable to the rest of the industry: HOLX outperforms 54.05% of its industry peers.
HOLX's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 24.55% | ||
| PM (TTM) | 13.79% | ||
| GM | 56.34% |
OM growth 3Y-18.26%
OM growth 5Y7.36%
PM growth 3Y-16.15%
PM growth 5YN/A
GM growth 3Y-5.85%
GM growth 5Y1.6%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so HOLX is still creating some value.
HOLX has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, HOLX has less shares outstanding
The debt/assets ratio for HOLX has been reduced compared to a year ago.
2.2 Solvency
HOLX has an Altman-Z score of 3.92. This indicates that HOLX is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.92, HOLX is in the better half of the industry, outperforming 74.59% of the companies in the same industry.
The Debt to FCF ratio of HOLX is 2.75, which is a good value as it means it would take HOLX, 2.75 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.75, HOLX belongs to the top of the industry, outperforming 87.03% of the companies in the same industry.
HOLX has a Debt/Equity ratio of 0.52. This is a neutral value indicating HOLX is somewhat dependend on debt financing.
HOLX has a worse Debt to Equity ratio (0.52) than 62.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | 2.75 | ||
| Altman-Z | 3.92 |
ROIC/WACC1.24
WACC8.06%
2.3 Liquidity
A Current Ratio of 3.55 indicates that HOLX has no problem at all paying its short term obligations.
With a decent Current ratio value of 3.55, HOLX is doing good in the industry, outperforming 65.41% of the companies in the same industry.
HOLX has a Quick Ratio of 2.81. This indicates that HOLX is financially healthy and has no problem in meeting its short term obligations.
HOLX has a better Quick ratio (2.81) than 66.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.55 | ||
| Quick Ratio | 2.81 |
3. Growth
3.1 Past
HOLX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.80%.
Measured over the past years, HOLX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.83% on average per year.
Looking at the last year, HOLX shows a small growth in Revenue. The Revenue has grown by 1.29% in the last year.
HOLX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.66% yearly.
EPS 1Y (TTM)4.8%
EPS 3Y-21.36%
EPS 5Y10.83%
EPS Q2Q%1.89%
Revenue 1Y (TTM)1.29%
Revenue growth 3Y-10.56%
Revenue growth 5Y3.66%
Sales Q2Q%1.23%
3.2 Future
The Earnings Per Share is expected to grow by 7.42% on average over the next years.
Based on estimates for the next years, HOLX will show a small growth in Revenue. The Revenue will grow by 4.28% on average per year.
EPS Next Y6.02%
EPS Next 2Y6.33%
EPS Next 3Y7.49%
EPS Next 5Y7.42%
Revenue Next Year1.61%
Revenue Next 2Y3.03%
Revenue Next 3Y3.75%
Revenue Next 5Y4.28%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 16.08, the valuation of HOLX can be described as correct.
Based on the Price/Earnings ratio, HOLX is valued cheaper than 85.95% of the companies in the same industry.
HOLX is valuated rather cheaply when we compare the Price/Earnings ratio to 27.14, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 14.46 indicates a correct valuation of HOLX.
HOLX's Price/Forward Earnings ratio is rather cheap when compared to the industry. HOLX is cheaper than 86.49% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of HOLX to the average of the S&P500 Index (22.80), we can say HOLX is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.08 | ||
| Fwd PE | 14.46 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HOLX indicates a rather cheap valuation: HOLX is cheaper than 87.03% of the companies listed in the same industry.
HOLX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HOLX is cheaper than 91.35% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.19 | ||
| EV/EBITDA | 11.93 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of HOLX may justify a higher PE ratio.
PEG (NY)2.67
PEG (5Y)1.48
EPS Next 2Y6.33%
EPS Next 3Y7.49%
5. Dividend
5.1 Amount
HOLX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
66.73
+0.1 (+0.15%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners105%
Inst Owner Change-0.75%
Ins Owners0.78%
Ins Owner Change0.37%
Market Cap14.84B
Analysts71.43
Price Target74.47 (11.6%)
Short Float %2%
Short Ratio2.09
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.06%
Min EPS beat(2)-0.63%
Max EPS beat(2)0.76%
EPS beat(4)1
Avg EPS beat(4)-0.69%
Min EPS beat(4)-2.26%
Max EPS beat(4)0.76%
EPS beat(8)5
Avg EPS beat(8)0.96%
EPS beat(12)9
Avg EPS beat(12)5.99%
EPS beat(16)13
Avg EPS beat(16)15.79%
Revenue beat(2)0
Avg Revenue beat(2)-0.83%
Min Revenue beat(2)-1.44%
Max Revenue beat(2)-0.21%
Revenue beat(4)0
Avg Revenue beat(4)-1.18%
Min Revenue beat(4)-2.22%
Max Revenue beat(4)-0.21%
Revenue beat(8)1
Avg Revenue beat(8)-0.83%
Revenue beat(12)5
Avg Revenue beat(12)0.96%
Revenue beat(16)9
Avg Revenue beat(16)4.67%
PT rev (1m)6.1%
PT rev (3m)6.8%
EPS NQ rev (1m)2.67%
EPS NQ rev (3m)-2.38%
EPS NY rev (1m)1.42%
EPS NY rev (3m)1.44%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)0.29%
Revenue NY rev (1m)0.36%
Revenue NY rev (3m)0.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.08 | ||
| Fwd PE | 14.46 | ||
| P/S | 3.67 | ||
| P/FCF | 16.19 | ||
| P/OCF | 13.88 | ||
| P/B | 3.06 | ||
| P/tB | 26.68 | ||
| EV/EBITDA | 11.93 |
EPS(TTM)4.15
EY6.22%
EPS(NY)4.61
Fwd EY6.91%
FCF(TTM)4.12
FCFY6.18%
OCF(TTM)4.81
OCFY7.2%
SpS18.16
BVpS21.77
TBVpS2.5
PEG (NY)2.67
PEG (5Y)1.48
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.33% | ||
| ROE | 11.5% | ||
| ROCE | 12.64% | ||
| ROIC | 10.03% | ||
| ROICexc | 13.19% | ||
| ROICexgc | 46.87% | ||
| OM | 24.55% | ||
| PM (TTM) | 13.79% | ||
| GM | 56.34% | ||
| FCFM | 22.7% |
ROA(3y)9.32%
ROA(5y)12.89%
ROE(3y)17.06%
ROE(5y)27.35%
ROIC(3y)11.66%
ROIC(5y)15.25%
ROICexc(3y)16.74%
ROICexc(5y)19.65%
ROICexgc(3y)75.27%
ROICexgc(5y)85.91%
ROCE(3y)14.69%
ROCE(5y)19.22%
ROICexcg growth 3Y-27.14%
ROICexcg growth 5Y-3.18%
ROICexc growth 3Y-24.3%
ROICexc growth 5Y7.08%
OM growth 3Y-18.26%
OM growth 5Y7.36%
PM growth 3Y-16.15%
PM growth 5YN/A
GM growth 3Y-5.85%
GM growth 5Y1.6%
F-Score6
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | 2.75 | ||
| Debt/EBITDA | 1.96 | ||
| Cap/Depr | 51.64% | ||
| Cap/Sales | 3.77% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 83.11% | ||
| Profit Quality | 164.55% | ||
| Current Ratio | 3.55 | ||
| Quick Ratio | 2.81 | ||
| Altman-Z | 3.92 |
F-Score6
WACC8.06%
ROIC/WACC1.24
Cap/Depr(3y)40.46%
Cap/Depr(5y)40.59%
Cap/Sales(3y)3.27%
Cap/Sales(5y)3.37%
Profit Quality(3y)165.37%
Profit Quality(5y)135.66%
High Growth Momentum
Growth
EPS 1Y (TTM)4.8%
EPS 3Y-21.36%
EPS 5Y10.83%
EPS Q2Q%1.89%
EPS Next Y6.02%
EPS Next 2Y6.33%
EPS Next 3Y7.49%
EPS Next 5Y7.42%
Revenue 1Y (TTM)1.29%
Revenue growth 3Y-10.56%
Revenue growth 5Y3.66%
Sales Q2Q%1.23%
Revenue Next Year1.61%
Revenue Next 2Y3.03%
Revenue Next 3Y3.75%
Revenue Next 5Y4.28%
EBIT growth 1Y7.45%
EBIT growth 3Y-26.89%
EBIT growth 5Y11.29%
EBIT Next Year13.14%
EBIT Next 3Y7.97%
EBIT Next 5Y7.8%
FCF growth 1Y10.21%
FCF growth 3Y-19.16%
FCF growth 5Y16.4%
OCF growth 1Y11.23%
OCF growth 3Y-17.99%
OCF growth 5Y14.62%